Business Wire · DCTH · October 19, 2026

Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma

Get the app for more

Explore stock news, insights and company research.